Literature DB >> 1764454

A comparative study on interactions of alpha-aminoisobutyric acid containing antibiotic peptides, trichopolyn I and hypelcin A with phosphatidylcholine bilayers.

K Matsuzaki1, T Shioyama, E Okamura, J Umemura, T Takenaka, Y Takaishi, T Fujita, K Miyajima.   

Abstract

Interactions of alpha-aminoisobutyric acid containing antibiotic peptides, trichopolyn I and hypelcin A with phosphatidylcholine bilayers were investigated to obtain some basic information on their bioactive mechanisms. Trichopolyn I as well as hypelcin A induced the leakage of a fluorescent dye, calcein, entrapped in sonicated egg yolk L-alpha-phosphatidylcholine vesicles. A quantitative analysis revealed that both the binding affinity and the 'membrane-perturbing activity' of trichopolyn I to the vesicles are about one-third of those of hypelcin A. The conformations and the orientations of the peptide and lipid molecules in the membranes were studied using polarized Fourier transform infrared-attenuated total reflection spectroscopy, circular dichroism, and differential scanning calorimetry. In phosphatidylcholine bilayers, both peptides mainly conformed to helical structures irrespective of the membrane physical state (gel or liquid-crystalline). The helix axes, penetrating the hydrophobic region of the bilayers, were oriented neither parallel nor perpendicular to the membrane normal. The disruption in the lipid packing induced by the peptide insertion seems to be responsible for the leakage by these peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764454     DOI: 10.1016/0005-2736(91)90082-j

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  On the physiology and pathophysiology of antimicrobial peptides.

Authors:  Roland Pálffy; Roman Gardlík; Michal Behuliak; Ludevit Kadasi; Jan Turna; Peter Celec
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

2.  Interfacial orientation and secondary structure change in tachyplesin I: molecular dynamics and sum frequency generation spectroscopy studies.

Authors:  Andrew P Boughton; Khoi Nguyen; Ioan Andricioaei; Zhan Chen
Journal:  Langmuir       Date:  2011-11-04       Impact factor: 3.882

3.  Interactions of membrane-active peptides with thick, neutral, nonzwitterionic bilayers.

Authors:  Kandaswamy Vijayan; Dennis E Discher; Jyotsana Lal; Paul Janmey; Mark Goulian
Journal:  J Phys Chem B       Date:  2005-08-04       Impact factor: 2.991

Review 4.  Human defensins.

Authors:  Josef Johann Schneider; Angela Unholzer; Martin Schaller; Monika Schäfer-Korting; Hans Christian Korting
Journal:  J Mol Med (Berl)       Date:  2005-04-09       Impact factor: 4.599

5.  Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay.

Authors:  Nadine C Gassner; Craig M Tamble; Jonathan E Bock; Naomi Cotton; Kimberly N White; Karen Tenney; Robert P St Onge; Michael J Proctor; Guri Giaever; Corey Nislow; Ronald W Davis; Phillip Crews; Theodore R Holman; R Scott Lokey
Journal:  J Nat Prod       Date:  2007-02-10       Impact factor: 4.050

6.  Antibacterial activity of human defensins against Staphylococcus aureus and Escherichia coli.

Authors:  Albert Bolatchiev
Journal:  PeerJ       Date:  2020-11-25       Impact factor: 2.984

7.  Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments.

Authors:  L M Gordon; S Horvath; M L Longo; J A Zasadzinski; H W Taeusch; K Faull; C Leung; A J Waring
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

Review 8.  Perspectives for clinical use of engineered human host defense antimicrobial peptides.

Authors:  María Eugenia Pachón-Ibáñez; Younes Smani; Jerónimo Pachón; Javier Sánchez-Céspedes
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

Review 9.  Focal Targeting of the Bacterial Envelope by Antimicrobial Peptides.

Authors:  Rafi Rashid; Mark Veleba; Kimberly A Kline
Journal:  Front Cell Dev Biol       Date:  2016-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.